MONTREAL, July 20 /PRNewswire-FirstCall/ - ORTHOsoft Inc. , an international company that develops and markets medical software, instruments and computer systems to increase the accuracy of knee, hip and spine surgery, today announced that it received confirmation from Le Ministere du Revenu du Quebec that its common shares qualify for the SME Growth Plan and are registered by the Autorite des Marches Financiers.
As a result, common shares of ORTHOsoft purchased on the secondary market to replace qualifying shares or securities sold by an individual qualify as valid shares for a "coverage" operation in accordance with the SME Growth Stock Plan.
"We are pleased that ORTHOsoft's common shares qualify for the Quebec SME Growth Stock Plan so that individuals now have an additional incentive for investing in the Company" said Dr. Louis-Philippe Amiot, Chairman and Co-CEO of ORTHOsoft Inc.
Further information on the SME Growth Stock Plan can be found on Le Ministere du Revenu du Quebec web site at: www.revenu.gouv.qc.ca.
Orthopaedic Surgery Market
In North America and Europe, surgeons perform over one million orthopaedic knee and hip implant surgeries annually. Many leading orthopaedic surgeons predict that computer assisted surgery will become a standard of care in implant surgery. To date, ORTHOsoft's computer assisted surgery systems have guided surgeons in more than 35,000 hip and knee surgeries in Europe and North America, and ORTHOsoft is well positioned to become a leader in the computer-assisted orthopaedic surgery market.
The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.
ORTHOsoft Inc. , www.orthosoft.ca, founded in 1995, develops and markets best-in-class medical software, instruments and computerized systems to assist orthopaedic surgeons to increase accuracy in hip, knee and spine implant surgery. FDA cleared, ORTHOsoft's patented software solutions are developed by surgeons for surgeons, resulting in intuitive and easy-to-use navigation that tracks surgical flow and provides surgeons with real-time data that helps to improve the surgical process and patient outcomes. For more information about ORTHOsoft, please visit www.orthosoft.ca.
Certain statements contained in this news release, other than statements of fact that are independently verifiable at the date hereof, may constitute forward-looking statements. Such statements, inherently involve numerous risks and uncertainties, known and unknown, many of which are beyond the control of ORTHOsoft, Inc. Such risks include, but are not limited to: the impact of general economic conditions, general conditions in the medical industry, and changes to the competitive environment in the jurisdictions in which ORTHOsoft does business, regulatory changes to the health care industry, and adequate protection of the proprietary interests of the Company. Consequently, actual future results may differ materially from the anticipated results expressed in the forward-looking statements. The reader should not place undue reliance on the forward-looking statements included in this press release. These statements speak only as of the date made, and ORTHOsoft is under no obligation and disavows any intention to update or revise such statements as a result of any event, circumstances, or otherwise.
CONTACT: ORTHOsoft Inc.: Peggy Katsiroumbas, CA, Chief Financial Officer,(514) 861-4074 ext. 221, email@example.com; John F. Feilders,PhD, President and Co-CEO, (514) 861-4074 ext.222,firstname.lastname@example.org; Echoes Financial Network Inc., Investors andMedia, Dominic Sicotte, 1 (866) 633-9551, email@example.com